GGrantIndex
← Search

T-CELL DEPLETED AUTO STEM CELL TRANPLANT FOR SSC

$494,890N01FY2000ARNIH

University Of Pittsburgh At Pittsburgh, Pittsburgh PA

Investigators

Linked publications & trials

Abstract

This is a pilot, open label-clinical trial designed to test the toxicity and potential efficacy of a new immunoablative and bone marrow suppressive combination regimen prior (preparative phase) to stem cell transplantation in patients with rapidly progressing cutaneous scleroderma.

View original record on NIH RePORTER →